X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1355) 1355
Publication (163) 163
Book Review (27) 27
Book Chapter (8) 8
Conference Proceeding (6) 6
Book / eBook (4) 4
Dissertation (3) 3
Newspaper Article (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (803) 803
index medicus (729) 729
female (553) 553
animals (472) 472
oncology (333) 333
male (308) 308
cancer (303) 303
adult (263) 263
middle aged (259) 259
immunology (246) 246
in-situ hybridization (239) 239
in situ hybridization (208) 208
vaccination (190) 190
aged (176) 176
immunohistochemistry (175) 175
immunotherapy (169) 169
mice (169) 169
human papillomavirus (167) 167
in-situ (164) 164
research (140) 140
health aspects (136) 136
cervical cancer (133) 133
pathology (132) 132
veterinary sciences (132) 132
infection (122) 122
papillomavirus infections (120) 120
analysis (118) 118
expression (116) 116
tumors (111) 111
diagnosis (110) 110
polymerase chain reaction (102) 102
risk factors (102) 102
vaccines (99) 99
dna (97) 97
young adult (95) 95
adolescent (94) 94
papillomavirus infections - virology (93) 93
apoptosis (92) 92
article (92) 92
in situ hybridization, fluorescence (92) 92
dendritic cells (91) 91
care and treatment (88) 88
hpv (87) 87
squamous-cell carcinoma (86) 86
aged, 80 and over (85) 85
medicine, research & experimental (85) 85
in situ nick-end labeling (81) 81
microbiology (81) 81
polymerase-chain-reaction (81) 81
prevalence (80) 80
virology (80) 80
papillomaviridae - isolation & purification (78) 78
uterine cervical neoplasms - virology (78) 78
women (78) 78
antigens (76) 76
infections (75) 75
papillomaviridae - genetics (75) 75
carcinoma in-situ (73) 73
papillomavirus infections - epidemiology (73) 73
infectious diseases (72) 72
carcinoma in situ - virology (71) 71
flow cytometry (69) 69
genetic aspects (68) 68
prevention (68) 68
in-situ vaccination (67) 67
research article (67) 67
viruses (67) 67
medicine (66) 66
risk (66) 66
lesions (65) 65
papillomavirus infections - complications (65) 65
reverse transcriptase polymerase chain reaction (65) 65
gene expression (64) 64
carcinoma in situ - pathology (62) 62
lymphocytes (62) 62
development and progression (61) 61
mice, inbred c57bl (61) 61
prognosis (61) 61
epidemiology (60) 60
proteins (60) 60
abridged index medicus (59) 59
cells (59) 59
squamous cell carcinoma (59) 59
therapy (59) 59
dna, viral - analysis (58) 58
human-papillomavirus (58) 58
t cells (58) 58
chemotherapy (57) 57
virus diseases (57) 57
carcinoma (55) 55
carcinoma in situ - epidemiology (55) 55
papillomaviruses (55) 55
surgery (55) 55
cell biology (54) 54
cervical intraepithelial neoplasia (54) 54
disease (54) 54
incidence (54) 54
immunization (53) 53
intraepithelial neoplasia (53) 53
obstetrics & gynecology (52) 52
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1351) 1351
French (7) 7
German (4) 4
Spanish (3) 3
Arabic (1) 1
Chinese (1) 1
Japanese (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2009, Volume 361, Issue 19, pp. 1838 - 1847
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 12/2019, Volume 110, Issue 12, pp. 3811 - 3820
The Japanese government began a human papillomavirus (HPV) vaccination program for girls aged 12‐16 years in 2010 but withdrew its recommendation in 2013... 
adenocarcinoma in situ | cervical cancer | cervical intraepithelial neoplasia | human papillomavirus | vaccination
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2010, Volume 107, Issue 26, pp. 11895 - 11899
One half of a group of 20 patients with human papillomavirus type 16 (HPV16)-induced vulvar intraepithelial neoplasia grade 3 displayed a complete regression... 
T lymphocytes | Antigens | Immune response | Cytokines | Vaccination | Lesions | Neoplasia | Immunity | Cervical cancer | Cancer | Human papilloma virus | Regulatory T cells | Therapeutic vaccine | Immunomonitoring | therapeutic vaccine | immunomonitoring | HEALTHY-SUBJECTS | MULTIDISCIPLINARY SCIENCES | ANTIGENS | human papilloma virus | CERVICAL-CANCER PATIENTS | CHRONIC VIRAL-INFECTION | INTRAEPITHELIAL NEOPLASIA | NATURAL-HISTORY | regulatory T cells | CD4+T-CELL IMMUNITY | CD4(+) | HUMAN-PAPILLOMAVIRUS INFECTIONS | T-Lymphocyte Subsets - immunology | Humans | Carcinoma in Situ - immunology | Human papillomavirus 16 - immunology | Papillomavirus Infections - therapy | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Papillomavirus Infections - pathology | Cancer Vaccines - therapeutic use | Vulvar Neoplasms - pathology | Vulvar Neoplasms - therapy | Forkhead Transcription Factors - metabolism | Treatment Failure | Papillomavirus Infections - immunology | Female | Papillomavirus Vaccines - administration & dosage | Vulvar Neoplasms - immunology | Papillomavirus Vaccines - therapeutic use | Carcinoma in Situ - pathology | Lymphocyte Activation | Cancer Vaccines - administration & dosage | Carcinoma in Situ - therapy | Remission Induction | Interleukin-2 Receptor alpha Subunit - metabolism | T-Lymphocytes - immunology | Kinetics | In Vitro Techniques | Cytokines - biosynthesis | Prevention | Genetic aspects | Research | T cells | Papillomavirus infections | Immunopharmacology | Biological Sciences
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 13, pp. 3929 - 3941
Journal Article